Providence Therapeutics CEO; Line 5 faces shutdown deadline; oil supply shortage?; vaccine communication; one-dose efficacy

from Afternoons with Rob Breakenridge · host CHQR / Curiouscast

Today's guests: Brad Sorenson, CEO - Providence Therapeutics Dennis Mcconaghy, Former Executive Vice-President at TransCanada Corporation. -Author and Energy commentator ( doce.ca ) Eric Nuttall, Partner, Senior Portfolio Manager- Ninepoint LP Dr. Harry Rakowski, Clinician Investigator, Toronto General Hospital Research Institute (TGHRI) Dr. Zain Chagla, Assistant Professor of Medicine at McMaster University / Doctor specializing in internal medicine, tropical medicine, and infectious diseases Learn more about your ad choices. Visit megaphone.fm/adchoices

Episode metadata supplied by the publisher feed · Published May 13, 2021

Embed this episode

Attribution link and audio player

NOW PLAYING

Providence Therapeutics CEO; Line 5 faces shutdown deadline; oil supply shortage?; vaccine communication; one-dose efficacy

0:00 59:14

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Afternoons with Rob Breakenridge?

This episode is 59 minutes long.

When was this Afternoons with Rob Breakenridge episode published?

This episode was published on May 13, 2021.

Can I download this Afternoons with Rob Breakenridge episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!